Xylem Reports Fourth Quarter and Full-year 2019 Earnings
Xylem Reports Fourth Quarter and Full-year 2019 Earnings




  • Full-year 2019 reported net income of $401 million or $2.21 per share; adjusted full-year net income of $547 million or $3.02 per share

  • Full-year free cash flow conversion was 124%

  • Fourth quarter 2019 reported net income was $118 million or $0.65 per share; adjusted net income of $161 million or $0.89 per share

  • Announces 8% increase in cash dividend, representing the company’s ninth consecutive annual dividend increase

  • Provides 2020 organic revenue growth guidance range of 1% to 3% and adjusted earnings per share range of $2.96 to $3.16






 



RYE BROOK, N.Y.- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported full-year 2019 revenue of $5.25 billion, up one percent on a reported basis and four percent on an organic basis. Full-year reported net income was $401 million, or $2.21 per share, with a reported operating margin of 9.3 percent. Adjusted net income, which excludes the impact of restructuring, realignment and special charges, was $547 million, or $3.02 per share. Adjusted earnings before interest, tax, depreciation and amortization (EBITDA) was 19.5 percent, flat year-over-year. Xylem delivered full-year 2019 adjusted operating margin of 13.9 percent, up 20 basis points versus the prior year. The Company generated $613 million in free cash flow, representing a 124 percent conversion.

In the fourth quarter 2019, Xylem generated net income of $118 million, or $0.65 per share, and adjusted net income of $161 million, or $0.89 per share, which excludes the impact of restructuring, realignment and special charges. Fourth quarter revenue was $1.37 billion reflecting ongoing softness in Industrial and Commercial end markets. Adjusted EBITDA declined 10 basis points to 20.5 percent. Reported operating margin in the quarter was 14.2 percent and adjusted operating margin declined 10 basis points year-over-year to 15.0 percent.

“Our teams continued to capitalize on Xylem’s portfolio of industry-leading technologies throughout 2019, again delivering mid-single-digit growth in the Utilities market globally, including double-digit growth in China and India,” said Patrick Decker, president and CEO of Xylem. “However, soft Industrial and Commercial markets in the second half slowed our overall revenue growth and margin progress for the year. In response to those challenges, we effectively contained costs, significantly improved working capital, and exceeded our free cash flow conversion commitments.”

“We’ve entered 2020 with strong operational discipline, solid foundations underpinning continued growth, and an energized global team leading the industry on sustainability,” Decker continued. “We’re confident we can manage through soft conditions persisting through the first half, and we foresee a moderate second-half recovery in our short-cycle businesses in parallel with ramp-ups in several large Utilities projects in our backlog. We expect a return to mid-single-digit growth in the second half of the year.”

Xylem announced that its Board of Directors declared a dividend in the amount of $0.26 per share, an increase of 8 percent. The dividend is payable on March 26, 2020, to shareholders of record as of February 27, 2020.

Full-year 2020 Outlook

Xylem forecasts full-year 2020 organic revenue in the range of $5.3 to $5.35 billion, up one to three percent.

Full-year 2020 adjusted operating margin is expected to be in the range of 14.0 to 14.5 percent, resulting in adjusted earnings per share of $2.96 to $3.16. This represents an increase of one to eight percent from Xylem’s 2019 adjusted results, excluding the impact of foreign exchange translation and a reduction in non-cash pension income. The Company’s adjusted earnings outlook excludes projected restructuring and realignment costs in the range of $35 million to $45 million for the year. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Fourth Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

  • Fourth quarter 2019 revenue was $603 million, up one percent organically compared with fourth quarter 2018. This increase was driven by solid results in the Utilities end market in the Emerging Markets and Europe. This was largely offset by declines in its short-cycle industrial dewatering business.

  • Fourth quarter reported operating income for the segment was $119 million. Adjusted operating income for the segment, which excludes $6 million of restructuring and realignment, was $125 million. Reported operating margin for the Water Infrastructure segment was 19.7 percent, up 20 basis points versus the prior year, and adjusted operating margin was 20.7 percent, flat with prior year. Strong productivity benefits and cost control offset inflation, lower volumes, and unfavorable mix from our high-margin Dewatering business.


Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, and industrial applications.

  • Fourth quarter 2019 Applied Water revenue was $392 million, a two percent decline organically year-over-year. Volume weakness in the Commercial and Industrial end markets continued in the quarter, with particular softness in the United States and Europe, partly offset by modest growth in Emerging Markets.

  • Fourth quarter reported operating income for the segment was $62 million and adjusted operating income, which excludes $3 million of restructuring and realignment costs, was $65 million, a six percent decrease versus the comparable period last year. The segment reported operating margin was 15.8 percent, down 60 basis points versus the prior year period. Adjusted operating margin declined 60 basis points to 16.6 percent. Strong productivity and price realization in the segment was more than offset by inflation, unfavorable mix, and lower volumes.


Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

  • Fourth quarter 2019 Measurement & Control Solutions revenue was $376 million, up two percent organically versus the prior year, driven by higher energy project deployments in the United States, and stronger international water metrology demand.

  • Fourth quarter reported operating income for the segment was $27 million, and adjusted operating income, which excludes $2 million of restructuring and realignment costs, was $29 million. Measurement & Control Solutions segment reported operating margin was 7.2 percent. Adjusted operating margin of 7.7 percent increased 20 basis points over the prior year period. Productivity benefits and price realization offset inflation and mix headwinds to modestly expand margins.


Supplemental information on Xylem’s fourth quarter 2019 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s more than 16,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York, with 2019 revenue of $5.25 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include any statements that are not historical in nature, including any statements about the capitalization of the Company, the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future - including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results - are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.

Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions; geopolitical and other risks associated with our international operations, including military actions, protectionism, economic sanctions or trade barriers including tariffs and embargoes that could affect customer markets and our business, and non-compliance with laws, including foreign corrupt practice laws, data privacy, export and import laws and competition laws; actual or potential pandemics; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; disruption, competition and pricing pressures in the markets we serve; industrial, governmental and private sector spending; the strength of housing and related markets; weather conditions; ability to retain and attract talent and key members of management; our relationship with and the performance of our supply chain including channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; changes in the value of goodwill or intangible assets; risks relating to product defects, product security, product liability and recalls; claims or investigations by governmental or regulatory bodies; cybersecurity attacks, breaches or other disruptions of information technology systems on which we rely; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018 ("2018 Annual Report") and with subsequent filings we make with the Securities and Exchange Commission ("SEC").

All forward-looking statements made herein are based on information currently available to the Company as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.


































































































































































































































































XYLEM INC. AND SUBSIDIARIES


CONSOLIDATED INCOME STATEMENTS (Unaudited)


(In Millions, except per share data)



Year Ended December 31,



2019


 

2018


 

2017



Revenue



$



5,249


   

$



5,207


   

$



4,707


 

Cost of revenue



3,203


   

3,181


   

2,860


 

Gross profit



2,046


   

2,026


   

1,847


 

Selling, general and administrative expenses



1,158


   

1,161


   

1,089


 

Research and development expenses



191


   

189


   

181


 

Restructuring and asset impairment charges



63


   

22


   

25


 

Goodwill impairment charge



148


   


   


 

Operating income



486


   

654


   

552


 

Interest expense



67


   

82


   

82


 

Other non-operating (expense) income, net



(4



)


 

13


   

6


 

Gain (loss) on sale of businesses



1


   


   

(10



)



Income before taxes



416


   

585


   

466


 

Income tax expense



15


   

36


   

136


 

Net income



401


   

549


   

330


 

Less: Net loss attributable to non-controlling interests




   


   

(1



)



Net income attributable to Xylem



$



401


   

$



549


   

$



331


 

Earnings per share:


         

Basic



$



2.23


   

$



3.05


   

$



1.84


 

Diluted



$



2.21


   

$



3.03


   

$



1.83


 

Weighted average number of shares:


         

Basic



180.0


 

179.8


 

179.6



Diluted



181.2


 

181.1


 

180.9




































































































































































































































































































XYLEM INC. AND SUBSIDIARIES


CONSOLIDATED BALANCE SHEETS (Unaudited)


(In Millions, except per share amounts)



December 31,



2019


 

2018



ASSETS


     

Current assets:


     

Cash and cash equivalents



$



724


   

$



296


 

Receivables, less allowances for discounts, returns and doubtful accounts of $35


and $35 in 2019 and 2018, respectively



1,036


   

1,031


 

Inventories



539


   

595


 

Prepaid and other current assets



151


   

172


 

Total current assets



2,450


   

2,094


 

Property, plant and equipment, net



658


   

656


 

Goodwill



2,839


   

2,976


 

Other intangible assets, net



1,174


   

1,232


 

Other non-current assets



589


   

264


 

Total assets



$



7,710


   

$



7,222


 

LIABILITIES AND STOCKHOLDERS’ EQUITY


     

Current liabilities:


     

Accounts payable



$



597


   

$



586


 

Accrued and other current liabilities



628


   

546


 

Short-term borrowings and current maturities of long-term debt



276


   

257


 

Total current liabilities



1,501


   

1,389


 

Long-term debt, net



2,040


   

2,051


 

Accrued postretirement benefits



445


   

400


 

Deferred income tax liabilities



310


   

303


 

Other non-current accrued liabilities



447


   

297


 

Total liabilities



4,743


   

4,440


 
       

Stockholders’ equity:


     

Common stock — par value $0.01 per share:


     

Authorized 750.0 shares, issued 193.9 and 192.9 shares in 2019 and 2018,


respectively



2


   

2


 

Capital in excess of par value



1,991


   

1,950


 

Retained earnings



1,866


   

1,639


 

Treasury stock – at cost 13.7 shares and 13.2 shares in 2019 and 2018,


respectively



(527



)


 

(487



)



Accumulated other comprehensive loss



(375



)


 

(336



)



Total stockholders’ equity



2,957


   

2,768


 

Non-controlling interest



10


   

14


 

Total equity



2,967


   

2,782


 

Total liabilities and stockholders’ equity



$



7,710


   

$



7,222


 


















































































































































































































































































































































































































































































































































































XYLEM INC. AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF CASH FLOWS (In Millions) (Unaudited)



Year Ended December 31,



2019


 

2018


 

2017



Operating Activities


         

Net income



$



401


   

$



549


   

$



330


 

Adjustments to reconcile net income to net cash provided by


operating activities:


         

Depreciation



117


   

117


   

109


 

Amortization



140


   

144


   

125


 

Deferred income taxes



(77



)


 

(47



)


 

(33



)



Share-based compensation



29


   

30


   

21


 

Restructuring and asset impairment charges



63


   

22


   

25


 

Goodwill impairment charge



148


   


   


 

(Gain)/loss from sale of businesses



(1



)


 


   

10


 

Other, net



9


   

9


   

19


 

Payments for restructuring



(30



)


 

(21



)


 

(28



)



Contributions to postretirement benefit plans



(19



)


 

(41



)


 

(33



)



Changes in assets and liabilities (net of acquisitions):


         

Changes in receivables



(23



)


 

(103



)


 

(79



)



Changes in inventories



47


   

(97



)


 

27


 

Changes in accounts payable



29


   

51


   

50


 

Changes in accrued liabilities



15


   

(6



)


 

28


 

Changes in accrued taxes



(13



)


 


   

104


 

Net changes in other assets and liabilities



4


   

(21



)


 

11


 

Net Cash — Operating activities



839


   

586


   

686


 

Investing Activities


         

Capital expenditures



(226



)


 

(237



)


 

(170



)



Proceeds from the sale of property, plant and equipment




   


   

1


 

Acquisitions of businesses and assets, net of cash acquired



(18



)


 

(433



)


 

(33



)



Proceeds from sale of businesses




   

22


   

16


 

Cash received from investments



11


   

11


   

10


 

Cash paid for investments



(7



)


 

(11



)


 

(11



)



Cash received from cross currency swaps



9


   


   


 

Other, net




   

5


   

6


 

Net Cash — Investing activities



(231



)


 

(643



)


 

(181



)



Financing Activities


         

Short-term debt issued, net



281


   

335


   


 

Short-term debt repaid, net



(254



)


 

(52



)


 

(282



)



Long-term debt issued, net




   

1


   


 

Long-term debt repaid, net




   

(120



)


 


 

Repurchase of common stock



(40



)


 

(59



)


 

(25



)



Proceeds from exercise of employee stock options



13


   

7


   

16


 

Dividends paid



(174



)


 

(152



)


 

(130



)



Other, net



(3



)


 


   


 

Net Cash — Financing activities



(177



)


 

(40



)


 

(421



)



Effect of exchange rate changes on cash



(3



)


 

(21



)


 

22


 

Net change in cash and cash equivalents



428


   

(118



)


 

106


 

Cash and cash equivalents at beginning of year



296


   

414


   

308


 

Cash and cash equivalents at end of year



$



724


   

$



296


   

$



414


 

Supplemental disclosure of cash flow information:


         

Cash paid during the year for:


         

Interest



$



77


   

$



78


   

$



78


 

Income taxes (net of refunds received)



$



107


   

$



75


   

$



57


 
                       


Xylem Inc. Non-GAAP Measures


Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of "free cash flow" does not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Sensus Acquisition Related Costs" defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.

“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs not included in "Sensus Acquisition Related Costs", non-cash impairment charges and other special non-operating items.

“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Xylem Inc. Non-GAAP Reconciliation  
Reported vs. Organic & Constant Currency Orders  
($ Millions)  
                                     
  (As Reported - GAAP)   (As Adjusted - Organic)   Constant Currency  
      (A)   (B)       (C)   (D)   (E) = B+C+D   (F) = E/A   (G) = (E - C) / A  
                                     
          Change   % Change   Acquisitions /
Divestitures
      Change   % Change      
  Orders   Orders   2019 v. 2018   2019 v. 2018     FX Impact   Adj. 2019 v. 2018   Adj. 2019 v. 2018      
 

2019


 

2018


                             
Year Ended December 31                                    
                                     
Xylem Inc.

5,339


 

5,437


 

(98)


 

-2%


 

17


 

129


 

48


 

1%


 

1%


 
                                     
Water Infrastructure

2,234


 

2,255


 

(21)


 

-1%


 

-


 

74


 

53


 

2%


 

2%


 
Applied Water

1,556


 

1,557


 

(1)


 

0%


 

-


 

29


 

28


 

2%


 

2%


 
Measurement & Control Solutions

1,549


 

1,625


 

(76)


 

-5%


 

17


 

26


 

(33)


 

-2%


 

-3%


 
                                     
Quarter Ended December 31                                    
                                     
Xylem Inc.

1,286


 

1,383


 

(97)


 

-7%


 

4


 

16


 

(77)


 

-6%


 

-6%


 
                                     
Water Infrastructure

530


 

584


 

(54)


 

-9%


 

-


 

10


 

(44)


 

-8%


 

-8%


 
Applied Water

387


 

395


 

(8)


 

-2%


 

-


 

3


 

(5)


 

-1%


 

-1%


 
Measurement & Control Solutions

369


 

404


 

(35)


 

-9%


 

4


 

3


 

(28)


 

-7%


 

-8%


 
                                     
Quarter Ended September 30                                    
                                     
Xylem Inc.

1,346


 

1,356


 

(10)


 

-1%


 

4


 

24


 

18


 

1%


 

1%


 
                                     
Water Infrastructure

586


 

537


 

49


 

9%


 

-


 

13


 

62


 

12%


 

12%


 
Applied Water

376


 

377


 

(1)


 

0%


 

-


 

6


 

5


 

1%


 

1%


 
Measurement & Control Solutions

384


 

442


 

(58)


 

-13%


 

4


 

5


 

(49)


 

-11%


 

-12%


 
                                     
Quarter Ended June 30                                    
                                     
Xylem Inc.

1,392


 

1,378


 

14


 

1%


 

7


 

33


 

54


 

4%


 

3%


 
                                     
Water Infrastructure

586


 

580


 

6


 

1%


 

-


 

16


 

22


 

4%


 

4%


 
Applied Water

399


 

401


 

(2)


 

0%


 

-


 

8


 

6


 

1%


 

1%


 
Measurement & Control Solutions

407


 

397


 

10


 

3%


 

7


 

9


 

26


 

7%


 

5%


 
                                     
Quarter Ended March 31                                    
                                     
Xylem Inc.

1,315


 

1,320


 

(5)


 

0%


 

2


 

56


 

53


 

4%


 

4%


 
                                     
Water Infrastructure

532


 

554


 

(22)


 

-4%


 

-


 

35


 

13


 

2%


 

2%


 
Applied Water

394


 

384


 

10


 

3%


 

-


 

12


 

22


 

6%


 

6%


 
Measurement & Control Solutions

389


 

382


 

7


 

2%


 

2


 

9


 

18


 

5%


 

4%


 
                                     














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
                                   
  (As Reported - GAAP)   (As Adjusted - Organic)   Constant Currency
      (A)   (B)       (C)   (D)   (E) = B+C+D   (F) = E/A   (G) = (E - C) / A
                                   
          Change   % Change   Acquisitions /
Divestitures
      Change   % Change    
  Revenue   Revenue   2019 v. 2018   2019 v. 2018     FX Impact   Adj. 2019 v. 2018   Adj. 2019 v. 2018    
 

2019


 

2018


                           
Year Ended December 31                                  
                                   
Xylem Inc.

5,249


 

5,207


 

42


 

1%


 

22


 

124


 

188


 

4%


 

3%


                                   
Water Infrastructure

2,177


 

2,176


 

1


 

0%


 

-


 

70


 

71


 

3%


 

3%


Applied Water

1,541


 

1,534


 

7


 

0%


 

-


 

29


 

36


 

2%


 

2%


Measurement & Control Solutions

1,531


 

1,497


 

34


 

2%


 

22


 

25


 

81


 

5%


 

4%


                                   
Quarter Ended December 31                                  
                                   
Xylem Inc.

1,371


 

1,386


 

(15)


 

-1%


 

4


 

17


 

6


 

0%


 

0%


                                   
Water Infrastructure

603


 

609


 

(6)


 

-1%


 

-


 

11


 

5


 

1%


 

1%


Applied Water

392


 

402


 

(10)


 

-2%


 

-


 

3


 

(7)


 

-2%


 

-2%


Measurement & Control Solutions

376


 

375


 

1


 

0%


 

4


 

3


 

8


 

2%


 

1%


                                   
Quarter Ended September 30                                  
                                   
Xylem Inc.

1,296


 

1,287


 

9


 

1%


 

4


 

24


 

37


 

3%


 

3%


                                   
Water Infrastructure

531


 

541


 

(10)


 

-2%


 

-


 

13


 

3


 

1%


 

1%


Applied Water

376


 

378


 

(2)


 

-1%


 

-


 

6


 

4


 

1%


 

1%


Measurement & Control Solutions

389


 

368


 

21


 

6%


 

4


 

5


 

30


 

8%


 

7%


                                   
Quarter Ended June 30                                  
                                   
Xylem Inc.

1,345


 

1,317


 

28


 

2%


 

9


 

32


 

69


 

5%


 

5%


                                   
Water Infrastructure

561


 

546


 

15


 

3%


 

-


 

16


 

31


 

6%


 

6%


Applied Water

394


 

388


 

6


 

2%


 

-


 

8


 

14


 

4%


 

4%


Measurement & Control Solutions

390


 

383


 

7


 

2%


 

9


 

8


 

24


 

6%


 

4%


                                   
Quarter Ended March 31                                  
                                   
Xylem Inc.

1,237


 

1,217


 

20


 

2%


 

5


 

51


 

76


 

6%


 

6%


                                   
Water Infrastructure

482


 

480


 

2


 

0%


 

-


 

30


 

32


 

7%


 

7%


Applied Water

379


 

366


 

13


 

4%


 

-


 

12


 

25


 

7%


 

7%


Measurement & Control Solutions

376


 

371


 

5


 

1%


 

5


 

9


 

19


 

5%


 

4%


                                   




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Xylem Inc. Non-GAAP Reconciliation            
Adjusted Operating Income            
($ Millions)            
                                           
                                           
   

Q1


 

Q2


 

Q3


 

Q4


 

YTD


           
   

2019



2018


 

2019



2018


 

2019



2018


 

2019



2018


 

2019



2018


           
  Total Revenue                                        
  • Total Xylem

1,237



1,217


 

1,345



1,317


 

1,296



1,287


 

1,371



1,386


 

5,249



5,207


           
  • Water Infrastructure

482



480


 

561



546


 

531



541


 

603



609


 

2,177



2,176


           
  • Applied Water

379



366


 

394



388


 

376



378


 

392



402


 

1,541



1,534


           
  • Measurement & Control Solutions

376



371


 

390



383


 

389



368


 

376



375


 

1,531



1,497


           
                                           
  Operating Income                                        
  • Total Xylem

109



113


 

171



171


 

11



176


 

195



194


 

486



654


           
  • Water Infrastructure

51



49


 

98



92


 

97



99


 

119



119


 

365



359


           
  • Applied Water

56



50


 

62



61


 

61



59


 

62



66


 

241



236


           
  • Measurement & Control Solutions

16



33


 

26



31


 

(136)



31


 

27



23


 

(67)



118


           
  • Total Segments

123



132


 

186



184


 

22



189


 

208



208


 

539



713


           
                                           
  Operating Margin                                        
  • Total Xylem

8.8%



9.3%


 

12.7%



13.0%


 

0.8%



13.7%


 

14.2%



14.0%


 

9.3%



12.6%


           
  • Water Infrastructure

10.6%



10.2%


 

17.5%



16.8%


 

18.3%



18.3%


 

19.7%



19.5%


 

16.8%



16.5%


           
  • Applied Water

14.8%



13.7%


 

15.7%



15.7%


 

16.2%



15.6%


 

15.8%



16.4%


 

15.6%



15.4%


           
  • Measurement & Control Solutions

4.3%



8.9%


 

6.7%



8.1%


 

-35.0%



8.4%


 

7.2%



6.1%


 

-4.4%



7.9%


           
  • Total Segments

9.9%



10.8%


 

13.8%



14.0%


 

1.7%



14.7%


 

15.2%



15.0%


 

10.3%



13.7%


           
                                           
  Special Charges                                        
  • Total Xylem

4



6


 

-



1


 

155



1


 

-



4


 

159



12


           
  • Water Infrastructure

-



-


 

-



-


 

-



-


 

-



2


 

-



2


           
  • Applied Water

-



-


 

-



-


 

-



-


 

-



-


 

-



-


           
  • Measurement & Control Solutions

4



2


 

-



1


 

155



-


 

-



2


 

159



5


           
  • Total Segments

4



2


 

-



1


 

155



-


 

-



4


 

159



7


           
                                           
  Restructuring & Realignment Costs                                        
  • Total Xylem

20



16


 

21



10


 

30



11


 

11



11


 

82



48


           
  • Water Infrastructure

9



5


 

9



5


 

7



5


 

6



5


 

31



20


           
  • Applied Water

3



3


 

4



2


 

3



2


 

3



3


 

13



10


           
  • Measurement & Control Solutions

8



8


 

8



3


 

20



4


 

2



3


 

38



18


           
  • Total Segments

20



16


 

21



10


 

30



11


 

11



11


 

82



48


           
                                           
  Adjusted Operating Income                                        
  • Total Xylem

133



135


 

192



182


 

196



188


 

206



209


 

727



714


           
  • Water Infrastructure

60



54


 

107



97


#

104



104


#

125



126


 

396



381


           
  • Applied Water

59



53


 

66



63


#

64



61


#

65



69


 

254



246


           
  • Measurement & Control Solutions

28



43


 

34



35


#

39



35


#

29



28


 

130



141


           
  • Total Segments

147



150


 

207



195


 

207



200


 

219



223


 

780



768


           
                                           
  Adjusted Operating Margin                                        
  • Total Xylem

10.8%



11.1%


 

14.3%



13.8%


 

15.1%



14.6%


 

15.0%



15.1%


 

13.9%



13.7%


           
  • Water Infrastructure

12.4%



11.3%


 

19.1%



17.8%


 

19.6%



19.2%


 

20.7%



20.7%


 

18.2%



17.5%


           
  • Applied Water

15.6%



14.5%


 

16.8%



16.2%


 

17.0%



16.1%


 

16.6%



17.2%


 

16.5%



16.0%


           
  • Measurement & Control Solutions

7.4%



11.6%


 

8.7%



9.1%


 

10.0%



9.5%


 

7.7%



7.5%


 

8.5%



9.4%


           
  • Total Segments

11.9%



12.3%


 

15.4%



14.8%


 

16.0%



15.5%


 

16.0%



16.1%


 

14.9%



14.7%


           
                                           















































































































































































































































































































































































































































































































































































































































































































































































































































Xylem Inc. Non-GAAP Reconciliation        
Adjusted Diluted EPS        
($ Millions, except per share amounts)        
           
                                 
    Q4 2019   Q4 2018        
   

As Reported


 

Adjustments


 

Adjusted


 

As Reported


 

Adjustments


 

Adjusted


       
  Total Revenue

1,371


 

-


 

1,371


 

1,386


 

-


 

1,386


       
  Operating Income

195


 

11


a

206


 

194


 

15


a

209


       
  Operating Margin

14.2%


     

15.0%


 

14.0%


     

15.1%


       
  Interest Expense

(15)


 

-


 

(15)


 

(19)


 

-


 

(19)


       
  Other Non-Operating Income (Expense)

(2)


 

8


b

6


 

4


 

1


 

5


       
  Gain/(Loss) From Sale of Businesses

-


 

-


 

-


 

-


 

-


 

-


       
  Income before Taxes

178


 

19


 

197


 

179


 

16


 

195


       
  Provision for Income Taxes

(60)


 

24


c

(36)


 

46


 

(82)


c

(36)


       
  Net Income Attributable to Xylem

118


 

43


 

161


 

225


 

(66)


 

159


       
  Diluted Shares

181.2


     

181.2


 

181.0


     

181.0


       
  Diluted EPS

$ 0.65


 

$ 0.24


 

$ 0.89


 

$ 1.24


 

$ (0.36)


 

$ 0.88


       
                                 
  Year-over-year currency translation impact on current year diluted EPS

$ (0.02)


 

$ -


 

$ (0.02)


                   
  Diluted EPS at Constant Currency

$ 0.67


 

$ 0.24


 

$ 0.91


                   
                                 
                                 
                                 
    Q4 YTD 2019   Q4 YTD 2018        
   

As Reported


 

Adjustments


 

Adjusted


 

As Reported


 

Adjustments



Adjusted


       
  Total Revenue

5,249


 

-


 

5,249


 

5,207


     

5,207


       
  Operating Income

486


 

241


a

727


 

654


 

60


a

714


       
  Operating Margin

9.3%


     

13.9%


 

12.6%


     

13.7%


       
  Interest Expense

(67)


 

-


 

(67)


 

(82)


 

-


 

(82)


       
  Other Non-Operating Income (Expense)

(4)


 

19


b

15


 

13


 

1


 

14


       
  Gain/(Loss) From Sale of Businesses

1


 

(1)


 

-


 

-


 

-


 

-


       
  Income before Taxes

416


 

259


 

675


 

585


 

61


 

646


       
  Provision for Income Taxes

(15)


 

(113)


c

(128)


 

(36)


 

(88)


c

(124)


       
  Net Income Attributable to Xylem

401


 

146


 

547


 

549


 

(27)


 

522


       
  Diluted Shares

181.2


     

181.2


 

181.1


     

181.1


       
  Diluted EPS

$ 2.21


 

$ 0.81


 

$ 3.02


 

$ 3.03


 

$ (0.15)


 

$ 2.88


       
                                 
  Year-over-year currency translation impact on current year diluted EPS

$ (0.09)


 

$ (0.02)


 

$ (0.11)


                   
  Diluted EPS at Constant Currency

$ 2.30


 

$ 0.83


 

$ 3.13


                   
                                 
     
                                 

a



Quarter: Restructuring & realignment costs of $11 million in both 2019 and 2018 and special charges of $4 million in 2018 ($2 million of acquisition related costs and $2 million of asset impairment).


     
         
 

Year-to-date: Restructuring & realignment costs of $82 million and $48 million in 2019 and 2018, respectively; special charges of $155 million of intangible asset and goodwill impairment and $4 million of acquisition related costs in 2019 and $10 million of acquisition related costs and $2 million of asset impairment costs in 2018.


     
         

b



Special charges related to incremental pension costs as a result of the planned buyout of our UK pension plan of $6 million for the fourth quarter and $17 million year-to-date and $2 million of other special charges.


     
         

c



Quarter: Net tax impact on restructuring & realignment costs of $2 million in both 2019 and 2018; $4 million of tax impact on special charges in 2019 and tax-related special items of $30 million positive impact from expense adjustments in 2019 and and $80 million negative impact from benefit adjustments in 2018.


     
         
 

Year-to-date: Net tax impact on restructuring & realignment costs of $19 million and $12 million in 2019 and 2018, respectively; $6 million and $1 million of tax impact on special charges in 2019 and 2018, respectively and tax-related special items of $88 million and $75 million negative impact from benefit adjustments in 2019 and 2018, respectively.


     
         















































































































































































































































































































































































































































































































































































































































































Xylem Inc. Non-GAAP Reconciliation  
Net Cash - Operating Activities vs. Free Cash Flow  
($ Millions)  
                                           
                                           
    Q1   Q2   Q3   Q4   Year-to-Date  
   

2019


 

2018


 

2019


 

2018


 

2019


 

2018


 

2019


 

2018


 

2019


 

2018


 
                                           
Net Cash - Operating Activities  

$ 83


 

$ 63


 

$ 123


 

$ 138


 

$ 245


 

$ 187


 

$ 388


 

$ 198


 

$ 839


 

$ 586


 
                                           
Capital Expenditures  

(69)


 

(61)


 

(60)


 

(50)


 

(46)


 

(60)


 

(51)


 

(66)


 

(226)


 

(237)


 
                                           
Free Cash Flow  

$ 14


 

$ 2


 

$ 63


 

$ 88


 

$ 199


 

$ 127


 

$ 337


 

$ 132


 

$ 613


 

$ 349


 
                                           
Cash paid for Sensus acquisition related costs  

-


 

(1)


 

-


 

-


 

-


 

-


 

-


 

-


 

-


 

(1)


 
                                           
Free Cash Flow, excluding Sensus Acquisition Related Costs

$ 14


 

$ 3


 

$ 63


 

$ 88


 

$ 199


 

$ 127


 

$ 337


 

$ 132


 

$ 613


 

$ 350


 
                                           
Net Income  

79


 

79


 

139


 

115


 

65


 

130


 

118


 

225


 

401


 

549


 
                                           
Gain/(Loss) from sale of businesses  

1


 

-


 

-


 

(2)


 

-


 

2


 

-


 

-


 

1


 

-


 
                                           
Special Charges - non-cash impairment  

(3)


 

-


 

-


 

-


 

(155)


 

-


 

-


 

(2)


 

(158)


 

(2)


 
                                           
Significant deferred tax benefit/(charge)  

-


 

-


 

-


 

-


 

97


 

-


 

(33)


 

84


 

64


 

84


 
                                           
Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items  

$ 81


 

$ 79


 

$ 139


 

$ 117


 

$ 123


 

$ 128


 

$ 151


 

$ 143


 

$ 494


 

$ 467


 
                                    `      
Free Cash Flow Conversion  

17%


 

4%


 

45%


 

75%


 

162%


 

99%


 

223%


 

92%


 

124%


 

75%


 
                                           






























































































































































































































































































































































































































































































































































































































































































































Xylem Inc. Non-GAAP Reconciliation  
EBITDA and Adjusted EBITDA by Quarter  
                     
($ Millions)  
                     

2019


 
  Q1   Q2   Q3   Q4   Total  
                     
Net Income

79


 

139


 

65


 

118


 

401


 
                     
Income Tax Expense

15


 

17


 

(77)


 

60


 

15


 
                     
Interest Expense (Income), net

17


 

18


 

14


 

13


 

62


 
Depreciation

29


 

29


 

30


 

29


 

117


 
Amortization

35


 

34


 

35


 

36


 

140


 
EBITDA

175


 

237


 

67


 

256


 

735


 
                     
Share-based Compensation

9


 

7


 

7


 

6


 

29


 
                     
Restructuring & Realignment

20


 

21


 

30


 

11


 

82


 
                     
Loss/(Gain) from sale of business

(1)


 

-


 

-


 

-


 

(1)


 
                     
Special Charges

4


 

-


 

166


 

8


 

178


 
                     
Adjusted EBITDA

207


 

265


 

270


 

281


 

1,023


 
                     
Revenue

1,237


 

1,345


 

1,296


 

1,371


 

5,249


 
                     
Adjusted EBITDA Margin

16.7%


 

19.7%


 

20.8%


 

20.5%


 

19.5%


 
                     

2018


 
  Q1   Q2   Q3   Q4   Total  
                     
Net Income

79


 

115


 

130


 

225


 

549


 
                     
Income Tax Expense

16


 

35


 

31


 

(46)


 

36


 
                     
Interest Expense (Income), net

20


 

20


 

20


 

18


 

78


 
Depreciation

29


 

29


 

29


 

30


 

117


 
Amortization

38


 

36


 

34


 

36


 

144


 
EBITDA

182


 

235


 

244


 

263


 

924


 
                     
Share-based Compensation

9


 

7


 

7


 

7


 

30


 
                     
Restructuring & Realignment

16


 

9


 

11


 

11


 

47


 
                     
Loss/(Gain) from sale of business

-


 

2


 

(2)


 

-


 

-


 
                     
Special Charges

6


 

1


 

1


 

4


 

12


 
                     
Adjusted EBITDA

213


 

254


 

261


 

285


 

1,013


 
                     
Revenue

1,217


 

1,317


 

1,287


 

1,386


 

5,207


 
                     
Adjusted EBITDA Margin

17.5%


 

19.3%


 

20.3%


 

20.6%


 

19.5%


 
                     


 


Author
Parul Dubey
Parul Dubey

Stormwater Interview with Robert Page, P.E., Vice President, HNTB

Stormwater Interview with Robert Page, P.E., Vice President, HNTB

TriMet’s Banfield Type 1 Substation Replacement Project

TriMet’s Banfield Type 1 Substation Replacement Project

February Issue 2026

February Issue 2026